WHO official fears the world hasn't done enough to increase infectious disease surveillance after COVID-19
Maria Van Kerkhove, the World Health Organization's COVID-19 technical lead, is worried "not enough is happening" around the globe to enhance infectious disease surveillance and implement other tactics that could prevent the next serious outbreak of a dangerous pathogen, she told Stat News in an interview about the WHO's forthcoming Scientific Advisory Group for the Origins of Novel Pathogens.
"I see some work in this area," Van Kerkhove said, noting that "there are a lot of calls for better surveillance in animal populations, there's a huge effort to increase sequencing capacity worldwide." But, even though she believes "we're better prepared than we were a year ago to" to face future public health crises, she doesn't think the efforts to bolster the arsenal against them are moving "fast enough."
"Preparedness and readiness is a constant," she told Stat. "It's not something that starts and stops. And I fear that we won't use this traumatic experience we're all in now to do enough ... I fear that we'll move on to the next crisis, because there are plenty more, before we're in a better position here." Read Van Kerkhove's full interview at Stat News.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
- 
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
 - 
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
 - 
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
 - 
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
 - 
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
 - 
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
 - 
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
 - 
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
 


